Layer interaction
Genomic, epigenetic, miRNA, protein, pathway, microbiome and cell-state signals can point in different directions unless they are interpreted together.
Multiomics Intelligence
BioAtlas Multiomics Intelligence connects genes, regulatory control, miRNA, epigenetics, proteins, pathways, cells, tissues, biomarkers, illness intelligence, microbiome context, and systems-state interpretation into a public-safe cross-domain reasoning layer.
+
Multiomics Intelligence
BioAtlas Multiomics Intelligence connects genes, regulatory control, miRNA, epigenetics, proteins, pathways, cells, tissues, biomarkers, illness intelligence, microbiome context, and systems-state interpretation into a public-safe cross-domain reasoning layer.
Why multiomics matters
Single-layer biology often misses the reason a system behaves the way it does. Multiomics lets BioAtlas explain how genomic context, regulatory RNA, epigenetic state, proteins, pathways, microbiome signals, targets, cells, and illness records can be interpreted together without exposing protected raw datasets.
+
Why multiomics matters
Single-layer biology often misses the reason a system behaves the way it does. Multiomics lets BioAtlas explain how genomic context, regulatory RNA, epigenetic state, proteins, pathways, microbiome signals, targets, cells, and illness records can be interpreted together without exposing protected raw datasets.
Mechanism context
BioAtlas uses multiomics context to explain why a target, pathway, biomarker, cell state or illness record may matter within a broader biological system.
Public-safe reasoning
The public layer shows orientation and scale without exposing protected raw datasets, governed register rows, evidence tensors or exportable graph assets.
Cross-estate navigation
Multiomics connects public routes across miRNA, epigenetics, pathways, targets, microbiome, cell atlas, systems biology, hallmarks and enzyme intelligence.
Coverage intelligence
The public page shows only source-backed scale indicators and architecture. Deeper register rows, graph traversal, evidence tensors, scoring, exports, and operational workbenches remain behind reviewed access.
+
Coverage intelligence
The public page shows only source-backed scale indicators and architecture. Deeper register rows, graph traversal, evidence tensors, scoring, exports, and operational workbenches remain behind reviewed access.
miRNA registry entries
2,824
Universal target registry targets
3,659
Microbiome crosswalk mappings
1,099
Cell physics profiles
212
Cell-system mapped cells
211
DNA canonical entities
60
Research bucket families
8
Evidence domains
BioAtlas Multiomics is organised as a cross-domain intelligence layer rather than a flat list of omics terms.
+
Evidence domains
BioAtlas Multiomics is organised as a cross-domain intelligence layer rather than a flat list of omics terms.
GenomicsTranscriptomicsmiRNA / small RNAEpigenomicsProteomicsPathway activityCell-state mappingCell communication networksTherapy response profilingPrecision medicineBiomarker discoveryPerturbation biology
Cross-domain reasoning
The Multiomics layer connects illness records, target maps, miRNA, pathways, enzymes, metabolics, hallmarks, ECS, microbiome, biomarkers, formulations, references, cell-state context, and systems-biology logic into a navigable reasoning surface.
+
Cross-domain reasoning
The Multiomics layer connects illness records, target maps, miRNA, pathways, enzymes, metabolics, hallmarks, ECS, microbiome, biomarkers, formulations, references, cell-state context, and systems-biology logic into a navigable reasoning surface.
Research provenance
Multiomics Intelligence is supported by public research orientation, DOI-linked records, registry summaries, source-backed counts, and protected evidence architecture. Public pages provide orientation and provenance only; they do not expose raw workbooks or governed graph exports.
+
Research provenance
Multiomics Intelligence is supported by public research orientation, DOI-linked records, registry summaries, source-backed counts, and protected evidence architecture. Public pages provide orientation and provenance only; they do not expose raw workbooks or governed graph exports.
Public proof, protected platform
The platform can be evaluated publicly without exposing the protected estate.
The public platform page explains the estate, engine families, proof layer, and access pathway. Deeper technical assets, app surfaces, raw datasets, and controlled demos remain protected until review.
Public layer
What can be seen publicly
public page summaries
route map and estate map
DOI and preprint links
research collection names
safe paper summaries
licence family names
buyer lane overview
safety and non-claims boundary
access request funnel
Protected layer
What requires review
protected manuscripts
private vault assets
raw datasets and data-room extracts
buyer packs and valuation notes
pricing and commercial terms
technical architecture detail
internal app surfaces
controlled demos
AI-use or derivative-use rights
Public visibility is not a licence. Public pages do not grant access to protected material, commercial terms, AI ingestion, derivative databases, model training, redistribution, replication, or clinical use.
Request reviewed Multiomics access
Protected Multiomics systems, evidence routing, deeper register views, commercial packaging, API scope, dataset export, AI-use rights, and graph-backed interpretation are released only through reviewed access.
+
Request reviewed Multiomics access
Protected Multiomics systems, evidence routing, deeper register views, commercial packaging, API scope, dataset export, AI-use rights, and graph-backed interpretation are released only through reviewed access.